120 related articles for article (PubMed ID: 1798648)
1. [The action of regulator peptides with different biological activities on the process of fibrin-monomer polymerization and on nonenzymatic fibrinolysis].
Ashmarin IP; Liapina LA; Pastorova VE; Kudriashov BA
Patol Fiziol Eksp Ter; 1991; (4):3-5. PubMed ID: 1798648
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of the effect of the thymus preparations thymoptin and thymalin on fibrin-monomer polymerization].
Pastorova VE; Liapina LA; Ashmarin IP; Kudriashov BA; Zazhireĭ VD
Farmakol Toksikol; 1989; 52(2):47-50. PubMed ID: 2744143
[TBL] [Abstract][Full Text] [Related]
3. [The effect of tuftsin on fibrin polymerization in vitro and on the hemostatic system when administered intravenously to healthy animals].
Ashmarin IP; Pastorova VE; Liapina LA; Kudriashov BA; Kalikhevich VN; Kamenskiĭ AA; Azieva LD
Izv Akad Nauk SSSR Biol; 1991; (2):302-6. PubMed ID: 2071756
[TBL] [Abstract][Full Text] [Related]
4. [The action of timoptin peptides on the hemostatic system].
Liapina LA; Pastorova VE; Kudriashov BA; Zazhireĭ VD; Sokolova EA; Livshits VA; Ashmarin IP
Izv Akad Nauk SSSR Biol; 1990; (3):377-82. PubMed ID: 2401769
[TBL] [Abstract][Full Text] [Related]
5. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary observations on the effect of sjamp on the fibrinolytic system].
Yang XG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):187-92. PubMed ID: 2150354
[TBL] [Abstract][Full Text] [Related]
7. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN
Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381
[TBL] [Abstract][Full Text] [Related]
8. [The effect of regulatory peptides with various biological activity on the fibrin polymerization process and non-enzymatic fibrinolysis. Hypophyseal and hypophthalamic hormones, liberin, ACTH, and its analogs].
Ashmarin IP; Liapina LA; Pastorova VE; Kudriashov BA
Vopr Med Khim; 1991; 37(1):85-6. PubMed ID: 1650060
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
Chek JB; Panchenko NI
East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
[TBL] [Abstract][Full Text] [Related]
10. [The antifibrinolytic action of the D-dimer fragment].
Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
[TBL] [Abstract][Full Text] [Related]
11. [Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator].
Shimonaeva EE; Liutova LV; Andreenko GV
Vopr Med Khim; 1981; 27(6):823-8. PubMed ID: 7199779
[TBL] [Abstract][Full Text] [Related]
12. [Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test)].
Vorlová Z; Dyr IE
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):967-70. PubMed ID: 94893
[No Abstract] [Full Text] [Related]
13. Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
McBane RD; Ford MA; Karnicki K; Stewart M; Owen WG
Thromb Haemost; 2000 Jul; 84(1):83-7. PubMed ID: 10928475
[TBL] [Abstract][Full Text] [Related]
14. A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides.
Edgington TS; Curtiss LK; Plow EF
J Immunol; 1985 Jan; 134(1):471-7. PubMed ID: 3964817
[TBL] [Abstract][Full Text] [Related]
15. [The effect of thymoptin on enzymatic fibrinolysis].
Andreenko GV; Ashmarin IP; Zazhireĭ VD; Livshits VA; Serebriakova TN; Podorol'skaia LV
Vopr Med Khim; 1989; 35(5):108-11. PubMed ID: 2617925
[TBL] [Abstract][Full Text] [Related]
16. [Effects of tissue-type plasminogen activator from a culture of calf kidney cells on hemostasis and fibrinolysis in experimental nephritis].
Andreenko GV; Podorol'skaia LV; Serebriakova TN; Liaginskiĭ AV; Egorov BB
Biull Eksp Biol Med; 1988 Oct; 106(10):424-6. PubMed ID: 3142531
[TBL] [Abstract][Full Text] [Related]
17. [The fibrinogen-fibrin-fibrinolysis system in rheumatoid arthritis].
Belitskaia GA; Palienko IA; Shevchenko LI; Fedorova NE
Vrach Delo; 1989 Jan; (1):47-50. PubMed ID: 2718445
[TBL] [Abstract][Full Text] [Related]
18. [A method of determining the anti-, de- and fibrin-polymerization activity of the blood plasma].
Pastorova VE; Liapina LA; Kudriashov BA; Tabakina TE
Lab Delo; 1990; (7):53-7. PubMed ID: 1699071
[TBL] [Abstract][Full Text] [Related]
19. Plasma cross-linked fibrin degradation product (XLFbDP) assays in an in vivo model of fibrinolysis.
Rowbotham BJ; Whitaker AN; Masci PP
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):653-61. PubMed ID: 2133245
[TBL] [Abstract][Full Text] [Related]
20. [Role of intermediate products of prothrombin proteolysis by thrombin in the stimulation of the anticoagulation system of blood].
Kudriashov BA; Strukova SM; Orlova AS; Liapina LA
Biull Eksp Biol Med; 1976 Oct; 82(10):1172-4. PubMed ID: 1029494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
